EGFR and breast cancer: Although propolin C, a biologically active analog of propolin G from Taiwanese propolis, shows activity that represses EMT-regulated migration and invasion via epidermal growth factor receptor (EGFR)-dependent pathway [41], the repression effects of propolin G on EMT-regulated cancer malignancy is still unclear, especially in breast cancer.